Skip to content
Recall Observatory FDA recall evidence

Drug product

Meprobamate, Tablets USP, 200 mg, 100 tablets; Rx only; Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USA; 173266; . Distributed by: Watson Pharma, Inc., NDC 9591-5239-01

D-203-2013

February 08, 2013

Class II

Product summary

Firm
Watson Laboratories Inc
Event
Event 64312
Status
Terminated
Classification
Class II
Quantity
9,824 bottles
Official record key
drug-enforcement:D-203-2013

Official wording

Reason: Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out of specification result for an impurity diphenyl sulfone .

Code information: 386585A, Exp. 02/13; 429104A, Exp. 06/13; 474487A, Exp. 11/13; 491671A, Exp.01/14.

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification